These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11390455)

  • 1. Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2.
    Zhang X; Wang JM; Gong WH; Mukaida N; Young HA
    J Immunol; 2001 Jun; 166(12):7104-11. PubMed ID: 11390455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
    Giri S; Rattan R; Singh AK; Singh I
    J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of interleukin-8 expression by prostaglandin D2 metabolite 15-deoxy-delta12, 14 prostaglandin J2 (15d-PGJ2) in human THP-1 macrophages.
    Fu Y; Luo N; Lopes-Virella MF
    Atherosclerosis; 2002 Jan; 160(1):11-20. PubMed ID: 11755918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma ligands differentially modulate muscle cell differentiation and MyoD gene expression via peroxisome proliferator-activated receptor gamma -dependent and -independent pathways.
    Hunter JG; van Delft MF; Rachubinski RA; Capone JP
    J Biol Chem; 2001 Oct; 276(41):38297-306. PubMed ID: 11477074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells.
    Lu Y; Zhou Q; Zhong F; Guo S; Hao X; Li C; Wang W; Chen N
    Nephron Exp Nephrol; 2013; 123(1-2):1-10. PubMed ID: 23887394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
    Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
    Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
    J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY; Tseng CC
    Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-Deoxy-delta 12,14-prostaglandin J2 inhibits the expression of granulocyte-macrophage colony-stimulating factor in endothelial cells stimulated with lipopolysaccharide.
    Imaizumi T; Kumagai M; Hatakeyama M; Tamo W; Yamashita K; Tanji K; Yoshida H; Satoh K
    Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):293-9. PubMed ID: 14518569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
    Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
    FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages.
    Kim HY; Kim HS
    Immunol Cell Biol; 2007 Jan; 85(1):60-7. PubMed ID: 17130903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
    Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome-proliferator-activated-receptor gamma (PPARgamma) independent induction of CD36 in THP-1 monocytes by retinoic acid.
    Han S; Sidell N
    Immunology; 2002 May; 106(1):53-9. PubMed ID: 11972632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor.
    Chung SW; Kang BY; Kim TS
    Mol Pharmacol; 2003 Nov; 64(5):1169-79. PubMed ID: 14573767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of peroxisome proliferator activated receptor-gamma and liver X receptor-alpha in the regulation of inflammation in macrophages.
    Piraino G; Cook JA; O'Connor M; Hake PW; Burroughs TJ; Teti D; Zingarelli B
    Shock; 2006 Aug; 26(2):146-53. PubMed ID: 16878022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway.
    Napimoga MH; Vieira SM; Dal-Secco D; Freitas A; Souto FO; Mestriner FL; Alves-Filho JC; Grespan R; Kawai T; Ferreira SH; Cunha FQ
    J Immunol; 2008 Jan; 180(1):609-17. PubMed ID: 18097063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2).
    Kielian T; McMahon M; Bearden ED; Baldwin AC; Drew PD; Esen N
    J Neurochem; 2004 Sep; 90(5):1163-72. PubMed ID: 15312171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) mediates repression of TNF-alpha by decreasing levels of acetylated histone H3 and H4 at its promoter.
    Engdahl R; Monroy MA; Daly JM
    Biochem Biophys Res Commun; 2007 Jul; 359(1):88-93. PubMed ID: 17532302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.